Abstract:AIM:To design and construct an exogenous multiple epitope of helper T lymphocytes (HTL), and to evaluate its effect on anti-HBs response through DNA immunization.METHODS:Artificial HTL epitope, PADRE and four other HTL epitopes from different proteins were linked together using splicing by overlap extension to generate exogenous multiple epitopes of HTL, MTE5. pcMTE5 and pcHB were generated by cloning MTE5 and fragments of HBV pre-S2/S gene into mammalian expression plasmid pcDNA3. Four chimeric plasmids were constructed by cloning MTE5 into the region of pre-S2 gene (Bam HI), 5' terminal of S gene (HincII, Xba I) and 3' terminal of S gene (Acc I) of pcHB respectively. BALB/c mice were used in DNA immunization of the recombinant plasmids. Anti-HBs was detected using Abbott IMx AUSAB test kits.RESULTS:The sequences of MTE5 and the 6 constructs of recombinant plasmids were confirmed to be correct by DNA sequencing. The anti-HBs response of the co-inoculation of pcHB and pcMTE5 was much higher than that of the inoculation of pcHB only (136.7+/-69.1 mIU/mL vs 27.6+/-17.3 mIU/mL, P<0.01, t = -6.56). Among the 4 chimeric plasmids, only the plasmid in which MTE5 was inserted into the pre-S2 region had good anti-HBs response (57.54+/-7.68 mIU/mL), and had no significant difference compared with those of pcHB and the co-inoculation of pcHB and pcMTE5.CONCLUSION:Exogenous multiple epitopes of HTL had immune enhancement when they were co-inoculated with pre-S2/S gene or inoculated in the chimeric form at a proper site of pre-S2/S gene of HBV. It might suggest that it was possible to improve hepatitis B vaccine using exogenous multiple epitopes of HTL. The antibody responses were very low using DNA immunization in the study. Thus, the immune enhancement effect of exogenous multiple epitopes of HTL has to be confirmed and the effect on overcoming the drawback of the polymorphism of HLA II antigens should also be evaluated after these chimeric plasmids are expressed in mammalian cell lines.

Construction and Verification of a Recombinant Plasmid Encoding HBV Surface Genes S and PreS2 As a Genetic Adjuvant

Protective Immune Response Against Toxoplasma Gondii Elicited by a Recombinant DNA Vaccine with a Novel Genetic Adjuvant.

[Construction of a Recombinant HBV DNA Vaccine and Its Evaluation for Specific Cellular Immune Response in Mice].

[Impact of Different Adjuvants on Immunogenicity of the HBV Particle Vaccine Containing the S + Pres1 Fusion Antigen in Balb/C Mice].

Construction of Eukaryotic Expression Plasmids of Hepatitis B Surface Antigen and Helper T Lymphocyte Epitope

Construction and Expression of Vector Containing Hepatitis B Virus Surface Antigen Gene and CpG Motifs

Construction and expression of recombinant eukaryotic expression vector containing hepatitis B virus surface antigen gene

Antibodized gene vaccine harboring to HBV PreS2/S gene can enhance HBV specific CTL response induced by gene immunization

Immune Response Enhanced by Genes Encoding IFN-alpha 8 and T Alpha 1 Co-Inoculated with HBV DNA Vaccine

A Modified Hepatitis B Surface Antigen Carrying Both Pres1 and Pres2 Epitopes

Immune Response Induced by Recombinant Plasmid Expressing Double Pres2 of Hepatitis B Virus Genome in Mice

Construction of HBV S Gene Recombinant and Its Immunity Induced in Mice

Generation of Hepatitis B Virus PreS2-S Antigen in Hansenula Polymorpha

Construction of Exogenous Multiple Epitopes of Helper T Lymphocytes and DNA Immunization of Its Chimeric Plasmid with HBV Pre-S2/s Gene.

Expression of the Presl Sequence of Hepatitis-B Fused to the C-Terminus of Hepatitis-B Surface-Antigen

Construction of Shuttle Expression Vector of Pre-S1 Gene and Truncated Core Gene of Hepatitis B Virus

Plasmid DNA Containing Multiple CpG Motifs Triggers a Strong Immune Response to Hepatitis B Surface Antigen when Combined with Incomplete Freund’s Adjuvant but Not Aluminum Hydroxide

The Study of Expression HBcAg and HBsAg Pres1 Epitope Peptide Fusion Protein

Expression, Purification and Preliminary Clinical Use of Recombinant Hbsag Gst-Pres1(21-47 Aa) Fusion Proteins

Secretory Expression of the Fusion Protein Composed of Human Il-2 and Pres Antigen of Hepatitis B Virus in Mammalian Cells

Cocktail DNA Vaccine Against Toxoplasma Gondii and Hepatitis B Virus Infections:ⅰ.Construction and Identification of a Eukaryotic Expression Plasmid Encoding a Fusion Protein of Hepatitis B Surface Antigen (hbsag) and T.gondii GRA1